HKMPF Stock: Hikma Pharmaceuticals PLC Stock Price, Analysis & Insights
Get live HKMPF stock price $19.29, comprehensive Hikma Pharmaceuticals PLC stock analysis, charts, news, and expert forecast. Real-time HKMPF stock data and investment insights.
Loading chart data...
Hikma Pharmaceuticals PLC (HKMPF) Overview
Hikma Pharmaceuticals PLC (HKMPF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, HKMPF trades at $19.29 with a market capitalization of 4.10B . Over the past 52 weeks, HKMPF has traded between $16.34 and $27.96 , with the current price positioned at approximately 25% of this ra...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 4.10B
- Current price: $19.29
- 52-week range: $16.34 - $27.96
- P/E ratio: 10.66
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Hikma Pharmaceuticals PLC is a global pharmaceutical firm engaged in the development, manufacturing, commercialization, and distribution of a wide array of medications, including its own branded products, licensed drugs, and generic formulations. The...
Company Information
- CEO
- Said Samih Taleb Darwazah
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 9500
Contact Information
- Website
- https://www.hikma.com
- Address
- 1 New Burlington Place
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 10.7)
✓ Lower volatility stock (Beta: 0.65) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Hikma Pharmaceuticals PLC shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Hikma Pharmaceuticals PLC
- ⚠Investors should consider how Hikma Pharmaceuticals PLC fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
4.10B
P/E Ratio (TTM)
10.66
Beta
0.65
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare HKMPF with peer companies:
- Price
- $9.37
- Market cap
- 4.20B
- Price
- $50.75
- Market cap
- 4.26B
- Price
- $2.34
- Market cap
- 6.20B
- Price
- $7.29
- Market cap
- 5.78B
- Price
- $5.50
- Market cap
- 5.84B
- Price
- $5.22
- Market cap
- 6.06B
- Price
- $14.55
- Market cap
- 6.84B
- Price
- $4.56
- Market cap
- 6.43B
- Price
- $100.00
- Market cap
- 4.38B
- Price
- $9.95
- Market cap
- 4.46B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.